Skip to main content
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.05
+0.46 (6.98%)
At close: Mar 9, 2026, 4:00 PM EDT
6.88
-0.17 (-2.41%)
After-hours: Mar 9, 2026, 7:14 PM EDT

Unicycive Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
23
Market Cap
151.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023675.00K-276.00K-29.02%
Dec 31, 2022951.00K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 127.63M
Sangamo Therapeutics 32.88M
Zentalis Pharmaceuticals 26.87M
Innate Pharma 14.84M
Fate Therapeutics 6.65M
Oramed Pharmaceuticals 2.00M
Connect Biopharma Holdings 762.00K
Artiva Biotherapeutics 251.00K
Revenue Rankings

UNCY News

More News